Filing metadata

Accession number
0000905148-25-001264
Form type
Form 3
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Apr 21, 2025
Reporting period
Apr 09, 2025
Description
Initial ownership

Explore SEC Filings Hub